LABCORP HOLDINGS INC. — Director's Dealing 2021

Feb 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-02-04

Reporting Person: Caveney Brian J (EVP, President of Diagnostics)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-04	Common Stock	M	560	—	Acquired	4841.1697	Direct
2021-02-04	Common Stock	F	190	$223.78	Disposed	4651.1697	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-04	Restricted Stock Unit	$	M	560	Disposed		Common Stock (560)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Amount includes 60.0439 shares acquired on December 31, 2020 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

F3: Stock withholding to satisfy tax withholding obligations.

F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 4, 2021.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.